Methyl 4-fluoro-2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 95.0%, 250mg

3-(3-Hydroxy-prop-1-ynyl)-benzoic acid methyl ester, 1g

3-Ethoxy-5-methyl-1H-pyrazole, 98+%, 2g

(5-Bromo-4-methylpyridin-2-yl)methanol, 95.0%, 1g

8-BROMOQUINOLIN-2(1H)-ONE, 95.0%, 100g

Praseodymium fluoride, anhydrous, 99.0%, 50g

Propylene glycol monoethyl ether, min 99%, for synthesis, 1L, plastic packaging.

(6-Bromoimidazo[1,2-a]pyridin-2-yl)acetic acid, 97.0%, 10g

N-Acetylneuraminic Acid>98.0%(T)(HPLC)5g

(S)-2-(2-(2-Aminoacetamido)acetamido)-3-phenylpropanoic acid, 95.0%, 10g

PHENYL 2-ETHYLBUTANOATE, 95%, 5g

1-Phenyl-1H-pyrazol-4-amine, 97%, 1g

6-TERT-BUTYL 4-ETHYL 2-HYDROXY-7,8-DIHYDROPYRIDO[4,3-D]PYRIMIDINE-4,6(5H)-DICARBOXYLATE, 95.0%, 250mg